James L. Tyree

Insider Reports History

Identity
Location
Abbott Park, IL
SEC record
Reporting signature
/s/ Thomas Zindrick, J.D. Attorney-in-Fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by James L. Tyree:

Form 4 holding Director

Assertio Holdings, Inc.

Security class
Common Stock
Shares / value
188,251
Estimated value
$210,502
Report date
14 Mar 2024
Price
$1.12
Ownership
Direct
Form 4 holding Director

GENELUX Corp

Security class
Stock Option (Right to Buy)
Shares / value
28,576
Estimated value
Report date
27 Aug 2025
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Director

Assertio Holdings, Inc.

Security class
Stock Option (right to buy)
Shares / value
3,821
Estimated value
Report date
10 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
$50.95
Ownership
Direct
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ChemoCentryx, Inc.

Security class
Stock Option
Shares / value
0
Estimated value
Report date
20 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James L. Tyree

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .